2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theSmall Molecule Drug Discovery Market?

The surge in the occurrence of chronic illnesses is projected to fuel the expansion of the small molecule drug discovery market. Chronic ailments are those that persist for a year or more, interfere with daily activities, require continuous medical attention, or a combination of these. Small molecule medicines can be used to manage chronic illnesses such as HIV, cancer, infections, heart disease, and kidney disease, and these drugs are typically more affordable for patients suffering from chronic conditions. Thus, the growing prevalence of chronic diseases is likely to stimulate the small molecule drug discovery market’s growth. For example, the National Institutes of Health (NIH), a renowned biomedical research organization from the US, projected in 2023 that the population of individuals 50 years and older with at least one chronic disease in the United States would grow by 99.5%, escalating from 71.522 million in 2020 to 142.66 million in 2050. Similarly, the populace affected by multimorbidity is anticipated to increase by 91.16%, ascending from 7.8304 million in 2020 to 14.968 million in 2050. Hence, the escalating prevalence of chronic diseases is propelling the advancement of the small molecule drug discovery market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

#How Will the CAGR of the Small Molecule Drug Discovery Market Influence Its Overall Growth by 2034?

The market size of small molecule drug discovery has seen robust growth in the past few years. It is projected to rise from $62.44 billion in 2024 to $68.57 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The historical growth can be credited to initiatives in drug repurposing, automation in the discovery of drugs, higher r&d investment, regulatory backing for drug creation, and progress in high-throughput screening.

In the coming years, the market size for small molecule drug discovery is predicted to experience significant growth, potentially reaching $106.91 billion in 2029 with a compound annual growth rate (CAGR) of 11.7%. The anticipated growth in the forecasted period can be credited to the emergence of new therapeutic targets, a focus on patient-oriented drug discovery, combination products of drug-device, leveraging real-world evidence, the incorporation of pharmacogenomics, and responses to global health difficulties. Key trends expected during this period consist of fragment-based drug discovery, the fusion of artificial intelligence with drug discovery, RNA-focused therapeutics, collaborations and partnerships, advancements in drug delivery, and the acceptance of organoids and 3D cell culture models.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9834

Which Upcoming Market Trends and Innovations Are Set to Influence theSmall Molecule Drug Discovery Market’s Path Forward?

The significant trend growing in prominence in the small molecule drug discovery market is technological advancements. Key players in the small molecule drug discovery market are prioritizing the development of innovative products. For example, Dotmatics, a digital science platform provider based in the US, introduced a new product called Small Molecule Drug Discovery Solution in January 2023. This unique solution has an integrated scientific R&D platform with pre-set workflows and enhanced data management abilities. Its purpose is to decrease operational inefficiencies and accelerate the conversion of insights into decisions.

Who Are the Dominant Market Players Pushing the Boundaries of theSmall Molecule Drug Discovery Market?

Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

What Are the Core Segments of the Small Molecule Drug Discovery Market, and How Do They Contribute to Growth?

The small molecule drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule Drugs, Biologic Drugs

2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:

1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs

2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp

What Regions Are Dominating the Small Molecule Drug Discovery Market Growth?

North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Small Molecule Drug Discovery Maret 2025, By The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Metabolic Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Central Nervous System Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: